Skip to content
AdminJun 9, 2017< 1 min read

Class of diabetes drug raises risk for diabetic ketoacidosis

A study published in the New England Journal of Medicine suggests that a new class of type 2 diabetes drugs, called sodium-glucose cotransporter-2 (SGLT2) inhibitors, may increase the risk of diabetic ketoacidosis.

Read More